263 related articles for article (PubMed ID: 33915696)
1. Dissolvable Microneedle Patches to Enable Increased Access to Vaccines against SARS-CoV-2 and Future Pandemic Outbreaks.
O'Shea J; Prausnitz MR; Rouphael N
Vaccines (Basel); 2021 Apr; 9(4):. PubMed ID: 33915696
[TBL] [Abstract][Full Text] [Related]
2. Microneedle patches for vaccination in developing countries.
Arya J; Prausnitz MR
J Control Release; 2016 Oct; 240():135-141. PubMed ID: 26603347
[TBL] [Abstract][Full Text] [Related]
3. A microneedle patch for measles and rubella vaccination: a game changer for achieving elimination.
Prausnitz MR; Goodson JL; Rota PA; Orenstein WA
Curr Opin Virol; 2020 Apr; 41():68-76. PubMed ID: 32622318
[TBL] [Abstract][Full Text] [Related]
4. Assessing the Potential Cost-Effectiveness of Microneedle Patches in Childhood Measles Vaccination Programs: The Case for Further Research and Development.
Adhikari BB; Goodson JL; Chu SY; Rota PA; Meltzer MI
Drugs R D; 2016 Dec; 16(4):327-338. PubMed ID: 27696306
[TBL] [Abstract][Full Text] [Related]
5. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.
Kim E; Erdos G; Huang S; Kenniston TW; Balmert SC; Carey CD; Raj VS; Epperly MW; Klimstra WB; Haagmans BL; Korkmaz E; Falo LD; Gambotto A
EBioMedicine; 2020 May; 55():102743. PubMed ID: 32249203
[TBL] [Abstract][Full Text] [Related]
6. Microneedle technology for potential SARS-CoV-2 vaccine delivery.
McNamee M; Wong S; Guy O; Sharma S
Expert Opin Drug Deliv; 2023 Jun; 20(6):799-814. PubMed ID: 37128730
[TBL] [Abstract][Full Text] [Related]
7. Technology update: dissolvable microneedle patches for vaccine delivery.
Rodgers AM; Cordeiro AS; Donnelly RF
Med Devices (Auckl); 2019; 12():379-398. PubMed ID: 31572025
[TBL] [Abstract][Full Text] [Related]
8. Skin delivery of trivalent Sabin inactivated poliovirus vaccine using dissolvable microneedle patches induces neutralizing antibodies.
Donadei A; Kraan H; Ophorst O; Flynn O; O'Mahony C; Soema PC; Moore AC
J Control Release; 2019 Oct; 311-312():96-103. PubMed ID: 31484041
[TBL] [Abstract][Full Text] [Related]
9. Potent immunogenicity and broad-spectrum protection potential of microneedle array patch-based COVID-19 DNA vaccine candidates encoding dimeric RBD chimera of SARS-CoV and SARS-CoV-2 variants.
Fan F; Zhang X; Zhang Z; Ding Y; Wang L; Xu X; Pan Y; Gong FY; Jiang L; Kang L; Ha Z; Lu H; Hou J; Kou Z; Zhao G; Wang B; Gao XM
Emerg Microbes Infect; 2023 Dec; 12(1):2202269. PubMed ID: 37038652
[TBL] [Abstract][Full Text] [Related]
10. Microneedle Patches as Drug and Vaccine Delivery Platform.
Li J; Zeng M; Shan H; Tong C
Curr Med Chem; 2017; 24(22):2413-2422. PubMed ID: 28552053
[TBL] [Abstract][Full Text] [Related]
11. Electroporation of a nanoparticle-associated DNA vaccine induces higher inflammation and immunity compared to its delivery with microneedle patches in pigs.
Bernelin-Cottet C; Urien C; McCaffrey J; Collins D; Donadei A; McDaid D; Jakob V; Barnier-Quer C; Collin N; Bouguyon E; Bordet E; Barc C; Boulesteix O; Leplat JJ; Blanc F; Contreras V; Bertho N; Moore AC; Schwartz-Cornil I
J Control Release; 2019 Aug; 308():14-28. PubMed ID: 31265882
[TBL] [Abstract][Full Text] [Related]
12. The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial.
Rouphael NG; Paine M; Mosley R; Henry S; McAllister DV; Kalluri H; Pewin W; Frew PM; Yu T; Thornburg NJ; Kabbani S; Lai L; Vassilieva EV; Skountzou I; Compans RW; Mulligan MJ; Prausnitz MR;
Lancet; 2017 Aug; 390(10095):649-658. PubMed ID: 28666680
[TBL] [Abstract][Full Text] [Related]
13. An ultra-low-cost electroporator with microneedle electrodes (ePatch) for SARS-CoV-2 vaccination.
Xia D; Jin R; Byagathvalli G; Yu H; Ye L; Lu CY; Bhamla MS; Yang C; Prausnitz MR
Proc Natl Acad Sci U S A; 2021 Nov; 118(45):. PubMed ID: 34670842
[TBL] [Abstract][Full Text] [Related]
14. A Newly Identified Spike Protein Targeted Linear B-Cell Epitope Based Dissolvable Microneedle Array Successfully Eliciting Neutralizing Activities against SARS-CoV-2 Wild-Type Strain in Mice.
Li L; Zhao Z; Yang X; Su Z; Li W; Chen S; Wang L; Sun T; Du C; Li Z; Yang Z; Li M; Wang T; Wang Y; Fan Y; Wang H; Zhang J
Adv Sci (Weinh); 2023 Jul; 10(20):e2207474. PubMed ID: 37162232
[TBL] [Abstract][Full Text] [Related]
15. Low Adenovirus Vaccine Doses Administered to Skin Using Microneedle Patches Induce Better Functional Antibody Immunogenicity as Compared to Systemic Injection.
Flynn O; Dillane K; Lanza JS; Marshall JM; Jin J; Silk SE; Draper SJ; Moore AC
Vaccines (Basel); 2021 Mar; 9(3):. PubMed ID: 33810085
[TBL] [Abstract][Full Text] [Related]
16. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
17. Thermostability of Measles and Rubella Vaccines in a Microneedle Patch.
Joyce JC; Collins ML; Rota PA; Prausnitz MR
Adv Ther (Weinh); 2021 Oct; 4(10):. PubMed ID: 34926791
[TBL] [Abstract][Full Text] [Related]
18. A TLR9-adjuvanted vaccine formulated into dissolvable microneedle patches or cationic liposomes protects against leishmaniasis after skin or subcutaneous immunization.
Lanza JS; Vucen S; Flynn O; Donadei A; Cojean S; Loiseau PM; Fernandes APSM; Frézard F; Moore AC
Int J Pharm; 2020 Aug; 586():119390. PubMed ID: 32540349
[TBL] [Abstract][Full Text] [Related]
19. Efficient Drug Delivery into Skin Using a Biphasic Dissolvable Microneedle Patch with Water-Insoluble Backing.
Li S; Xia D; Prausnitz MR
Adv Funct Mater; 2021 Oct; 31(44):. PubMed ID: 34744551
[TBL] [Abstract][Full Text] [Related]
20. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
Frederiksen LSF; Zhang Y; Foged C; Thakur A
Front Immunol; 2020; 11():1817. PubMed ID: 32793245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
